Re: TRIALS SITE/ SHOWS TWO APPROVED TRIALS

...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Reply New Message

Prev Message Back To Forum Threaded View Next Message

BearDownAZ

Rank: President [?]

Points: 25003 [?]

Votes: 68 Score: 4.5 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: TRIALS SITE/ SHOWS TWO APPROVED TRIALS

in response to

Re: TRIALS SITE/ SHOWS TWO APPROVED TRIALS

PVLee

posted on Jun 16, 2016 01:22PM

PVLee,

Most of your questions can be answered by looking at the Eligibility Inclusion criteria for the two trials NCT02705469 and NCT02711956. In terms of seeing results "quickly by virtue of those patients hopefully still being with us" remember that the first step is dose-escalation of ZEN003694 in 28 day cycles to determine optimal dose for efficacy and dose-limiting toxicities. But yes, patient survival would be a great indication that it's working.